Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

By sjmartinez • January 3, 2025

Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford SL, Hendrix CW, Rinehart AR, Rooney JF, Adeyeye A, Landovitz RJ, Cohen MS, Hosseinipour MC, Marzinke MA; HPTN 084 Study Team. Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084. J Int AIDS Soc. 2025 Jan;28(1):e26401. doi: 10.1002/jia2.26401. PMID: 39748218.

Tags: Cabotegravir, HIV prevention, Infectious Diseases, long‐acting, pregnancy, PrEP, Publications, Women

Related Posts

Clinical utility of serial plasma cell-free DNA metagenomic next-generation sequencing assays

Kaur I, Shaw B, Multani A, Malhotra S, Dong HV, Lukose C, Prabaker K, Saleh T, Sim YB, Tymchuk CN, Uslan DZ, Zhou H, Brewer[...]

Infections After Kidney Transplantation From Donors With Human Immunodeficiency Virus (HIV) to Recipients With HIV

Arant EC, Davy-Mendez T, Liang T, Rodrigues M, Gay CL, Rana MM, Friedman-Moraco R, Gilbert A, Stock P, Mehta SA, Mehta S, Stosor V, Pereira[...]

Exploration of Pregnant and Breastfeeding Women’s Acceptability of Rapid Point-of-Care Urine Testing Within Antenatal and Postnatal Care, and Its Perceived Impact on PrEP Adherence When Paired with PrEP Biofeedback Adherence Counselling in Cape Town, South Africa

Court L, Mvududu R, Schoetz Dean S, Knight L, Dovel K, Gandhi M, Myer L, Coates T, Joseph Davey DL. Exploration of Pregnant and Breastfeeding[...]